These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 23892791)

  • 1. Cannabinoids decrease the th17 inflammatory autoimmune phenotype.
    Kozela E; Juknat A; Kaushansky N; Rimmerman N; Ben-Nun A; Vogel Z
    J Neuroimmune Pharmacol; 2013 Dec; 8(5):1265-76. PubMed ID: 23892791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells.
    Kozela E; Juknat A; Gao F; Kaushansky N; Coppola G; Vogel Z
    J Neuroinflammation; 2016 Jun; 13(1):136. PubMed ID: 27256343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells.
    Kozela E; Juknat A; Kaushansky N; Ben-Nun A; Coppola G; Vogel Z
    J Neuroinflammation; 2015 Mar; 12():52. PubMed ID: 25880134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.
    Al-Ghezi ZZ; Busbee PB; Alghetaa H; Nagarkatti PS; Nagarkatti M
    Brain Behav Immun; 2019 Nov; 82():25-35. PubMed ID: 31356922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways.
    Al-Ghezi ZZ; Miranda K; Nagarkatti M; Nagarkatti PS
    Front Immunol; 2019; 10():1921. PubMed ID: 31497013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells.
    Kozela E; Pietr M; Juknat A; Rimmerman N; Levy R; Vogel Z
    J Biol Chem; 2010 Jan; 285(3):1616-26. PubMed ID: 19910459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
    Rahimi A; Faizi M; Talebi F; Noorbakhsh F; Kahrizi F; Naderi N
    Neuroscience; 2015 Apr; 290():279-87. PubMed ID: 25637488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases.
    Rodríguez Mesa XM; Moreno Vergara AF; Contreras Bolaños LA; Guevara Moriones N; Mejía Piñeros AL; Santander González SP
    Cannabis Cannabinoid Res; 2021 Jun; 6(3):196-210. PubMed ID: 34030476
    [No Abstract]   [Full Text] [Related]  

  • 9. HU-446 and HU-465, Derivatives of the Non-psychoactive Cannabinoid Cannabidiol, Decrease the Activation of Encephalitogenic T Cells.
    Kozela E; Haj C; Hanuš L; Chourasia M; Shurki A; Juknat A; Kaushansky N; Mechoulam R; Vogel Z
    Chem Biol Drug Des; 2016 Jan; 87(1):143-53. PubMed ID: 26259697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-mediated effects of Δ
    Preteroti MW; Traboulsi H; Greiss P; Lapohos O; Fonseca GJ; Eidelman DH; Baglole CJ
    Immunol Cell Biol; 2023 Feb; 101(2):156-170. PubMed ID: 36510483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin gene-related peptide enhances experimental autoimmune encephalomyelitis by promoting Th17-cell functions.
    Mikami N; Watanabe K; Hashimoto N; Miyagi Y; Sueda K; Fukada S; Yamamoto H; Tsujikawa K
    Int Immunol; 2012 Nov; 24(11):681-91. PubMed ID: 22843730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro.
    Watzl B; Scuderi P; Watson RR
    Int J Immunopharmacol; 1991; 13(8):1091-7. PubMed ID: 1667651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis.
    Domingues HS; Mues M; Lassmann H; Wekerle H; Krishnamoorthy G
    PLoS One; 2010 Nov; 5(11):e15531. PubMed ID: 21209700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of human and mouse Th17 differentiation and autoimmunity by an endogenous Interleukin 23 receptor cytokine-binding homology region.
    Guo W; Luo C; Wang C; Wang YH; Wang X; Gao XD; Yao WB
    Int J Biochem Cell Biol; 2014 Oct; 55():304-10. PubMed ID: 25263529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of the cytokine signature by various TLR ligands in different T cell populations in MOG37-50 and MOG35-55-induced EAE in C57BL/6 mice.
    Steckner C; Weber A; Mausberg AK; Heininger M; Opdenhövel F; Kieseier BC; Hartung HP; Hofstetter HH
    Clin Immunol; 2016 Sep; 170():22-30. PubMed ID: 27233983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis.
    González-García C; Torres IM; García-Hernández R; Campos-Ruíz L; Esparragoza LR; Coronado MJ; Grande AG; García-Merino A; Sánchez López AJ
    Exp Neurol; 2017 Dec; 298(Pt A):57-67. PubMed ID: 28867485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Critical Review of the Role of the Cannabinoid Compounds Δ
    Jones É; Vlachou S
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
    Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
    PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells.
    Kato H; Ito A; Kawanokuchi J; Jin S; Mizuno T; Ojika K; Ueda R; Suzumura A
    Mult Scler; 2004 Dec; 10(6):651-9. PubMed ID: 15584490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.